# AHOD0831 (NCT01026220)

> Combination Chemotherapy and Radiation Therapy in Treating Young Patients With Newly Diagnosed Hodgkin Lymphoma

No report yet. It can be ordered.

## Registry

- Registry record: https://clinicaltrials.gov/study/NCT01026220
- Phase: PHASE3
- Status: COMPLETED
- Sponsor: Children's Oncology Group
- Conditions: Childhood Nodular Lymphocyte Predominant Hodgkin Lymphoma; Stage III Childhood Hodgkin Lymphoma; Stage IV Childhood Hodgkin Lymphoma
- Interventions: bleomycin sulfate; doxorubicin hydrochloride; liposomal vincristine sulfate; vinorelbine tartrate; cyclophosphamide; etoposide phosphate; prednisone; filgrastim; ifosfamide
- Enrollment: 166
- Primary outcome: Second-event-free Survival
- Primary outcome: Safety Analysis and Monitoring of Toxic Death

## Indexed commentary on AHOD0831 so far

Podcasts, YouTube videos and X posts we have indexed that name the trial. This is where a report starts, not where it ends: the build searches for more, so finished reports usually cover more than this.

- 3 posts on X

## Order

Focused, $750 at most (a smaller delivered size costs its own price): https://www.erudio.com/contact?report=ahod0831-nct01026220